Skip to main content
. 2024 Jan 5;23(1):74–82. doi: 10.18502/cjn.v23i1.16437

Table 1.

Demographic and clinical characteristics of the patients and controls

Characteristics Cases (n = 59) Controls (n = 65) P
Gender [n (%)]
     Men 42 (71.20) 43 (68.25) 0.900*
     Women 17 (28.80) 20 (31.75)
Age (year) (mean ± SD) 63.90 ± 1.80 64.66 ± 1.70 0.900**
BMI (kg/m2) (mean ± SD) 26.15 ± 0.60 25.81 ± 3.97 0.900**
NIHSS at admission [n (%)]
     ≤ 6 22 (37.30)
     ≥ 7 37 (62.70)
Aspect [n (%)]
     < 6 14 (23.70)
     ≥ 6 45 (76.30)
mRS at admission [n (%)]
     0-2 12 (20.33)
     3-6 47 (79.66)
mRS at 3 months [n (%)]
     0-2 24 (40.67)
     3-6 35 (59.32)
Vascular risk factors [n (%)]
HTN
     Yes 31 (52.50) 19 (30.15) 0.010*
     No 28 (47.50) 44 (69.84)
Diabetes
     Yes 21 (35.60) 10 (15.88) 0.010*
     No 38 (64.40) 53 (84.12)
Smoking
     Yes 10 (15.90) 8 (12.69) 0.300*
     No 49 (83.10) 55 (87.30)
Drinking
     Yes 2 (3.40) 2 (3.18) 0.600*
     No 57 (96.60) 61 (96.82)
HLP
     Yes 19 (32.20) 19 (30.15) 0.400*
     No 40 (67.80) 44 (69.84)
Laboratory findings (mean ± SD)
TG (mg/dl) 126.70 ± 7.08 132.81 ± 9.80 0.600**
Total cholesterol (mg/dl) 161.20 ± 5.60 162.19 ± 4.10 0.900**
LDL (mg/dl) 97.60 ± 4.50 90.60 ± 3.70 0.200**
HDL (mg/dl) 33.70 ± 0.90 44.21 ± 1.50 0.003**
Types of stroke [n (%)]
     LAA 29 (49.20) -
     SVD 30 (50.80) -

HTN: Hypertension; LDL: Low-density lipoprotein; HDL: High-density lipoprotein; HLP: Hyperlipidemia; TG: Triglyceride; LAA: Large-artery atherosclerosis; SVD: Small-vessel disease; BMI: Body mass index; NIHSS: National Institutes of Health Stroke Scale; mRS: Modified Rankin scale; SD: Standard deviation

*

Chi-square test;

**

Independent two-sample t-test